New cerium(III) and neodymium(III) complexes as cytotoxic agents

The cerium(III) and neodymium(III) complexes of 5-aminoorotic acid were synthesized and characterized by means of spectral data (IR, Raman, 1H NMR and 13C NMR) and elemental analysis. Significant differences in the IR spectra of the complexes were observed as compared with the spectrum of the ligand. A comparative analysis of the Raman spectra of the complexes with that of the free 5-aminoorotic acid allowed a straightforward assignment of the vibrations of the ligand groups involved in coordination. 1H NMR and 13C NMR spectra confirmed the formation of the complexes. The ligand and the complexes were tested for the cytotoxic activities on the chronic myeloid leukemia-derived K-562, overexpressing the BCR-ABL fusion protein, and the non-Hodgkin lymphoma-derived DOHH-2, characterized by a rexpression of the antiapoptotic protein bcl-2 cell lines. The results obtained indicate that the tested compounds exerted a considerable cytotoxic activity upon the evaluated cell lines in a concentration-dependent manner, which enabled the construction of dose–response curves and the calculation of the corresponding IC50 values. Cytotoxicity towards tumor cells was determined for a broad concentration range. The inorganic salts exerted a very weak cytotoxic effect on these cells that is in contrast to the lanthanide complexes, which exhibited potent cytotoxic activity towards K-562 and DOHH-2 cell lines. Copyright © 2006 John Wiley & Sons, Ltd.

[1]  N. Trendafilova,et al.  Theoretical and spectroscopic studies of pyridyl substituted bis-coumarins and their new neodymium (III) complexes , 2005 .

[2]  I. Kostova,et al.  Cytotoxic activity of new lanthanum (III) complexes of bis-coumarins. , 2005, European journal of medicinal chemistry.

[3]  N. Trendafilova,et al.  Antineoplastic activity of new lanthanide (cerium, lanthanum and neodymium) complex compounds. , 2005, Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements.

[4]  N. Trendafilova,et al.  Theoretical and spectroscopic evidence for coordination ability of 3,3'-benzylidenedi-4-hydroxycoumarin. New neodymium (III) complex and its cytotoxic effect. , 2005, Journal of inorganic biochemistry.

[5]  I. Kostova,et al.  Cytotoxic activity of new neodymium (III) complexes of bis-coumarins. , 2004, European journal of medicinal chemistry.

[6]  I. Kostova,et al.  Stability of the complexes of some lanthanides with coumarin derivatives. II. Neodymium(III)-acenocoumarol. , 2004, Acta pharmaceutica.

[7]  I. Kostova,et al.  Stability of the complexes of some lanthanides with coumarin derivatives. I. Cerium(III)-4-methyl-7-hydroxycoumarin. , 2004, Acta pharmaceutica.

[8]  D. Michalska,et al.  Revised molecular structure and vibrational spectra of tetraaqua(orotato)nickel(II) monohydrate: band assignment based on density functional calculations , 2002 .

[9]  S. Bekiroğlu,et al.  Hydrogen-bonded neutral and anionic lamellar networks: Crystal structures of bis(O,O′,O″-hydroorotato)disilver(I) dihydrate, potassium hydroorotate and rubidium hydroorotate. Ab initio calculations on orotic acid and the hydroorotate anion , 2002 .

[10]  R. Cao,et al.  Preparations, structures, and magnetic properties of a series of novel copper(II)-lanthanide(III) coordination polymers via hydrothermal reaction. , 2001, Inorganic chemistry.

[11]  I. Kostova,et al.  New metal complexes of 4-methyl-7-hydroxycoumarin sodium salt and their pharmacological activity. , 2001, Farmaco.

[12]  I. Kostova,et al.  New lanthanide complexes of 4-methyl-7-hydroxycoumarin and their pharmacological activity. , 2001, European journal of medicinal chemistry.

[13]  V. Psycharis,et al.  Synthesis and Structural, Spectroscopic, and Magnetic Characterization of (NH4)[Fe3(μ3-OH)(H2L)3(HL)3] (H3L = Orotic Acid) Presenting Two Novel Metal-Binding Modes of the Orotate Ligand: The Case of a Spin-Frustrated System , 2000 .

[14]  T. Furukawa,et al.  Resistance to cisplatin. , 1999, Anti-cancer drug design.

[15]  L. Pellerito,et al.  Organometallic complexes with biological molecules. X : Dialkyltin(IV) and trialkyltin(IV) orotates : Spectroscopic and in vivo investigations , 1999 .

[16]  I. Kostova,et al.  Synthesis, physicochemical characterisation and cytotoxic screening of new complexes of cerium, lanthanum and neodymium with Warfarin and Coumachlor sodium salts , 1999 .

[17]  D. Darensbourg,et al.  Bis(triphenylphosphine)copper(I) Complexes of Orotate and L-Dihydroorotate. , 1998, Inorganic chemistry.

[18]  D. Darensbourg,et al.  ORGANOMETALLIC DERIVATIVES OF OROTIC ACID. CO-LABILIZING ABILITY OF THE AMIDO GROUP IN CHROMIUM AND TUNGSTEN CARBONYL COMPLEXES , 1998 .

[19]  Andrew J. P. White,et al.  Orotate complexes of rhodium(I) and iridium(I): effect of coligand, counter ion, and solvent of crystallisation on association via complementary hydrogen bonding , 1998 .

[20]  A. Terzis,et al.  New metal-binding modes for 5-aminoorotic acid: preparation, characterization and crystal structures of zinc(II) complexes , 1998 .

[21]  M. Ruf,et al.  Pyrazolylborate-Zinc Complexes of RNA Precursors and Analogues Thereof. , 1997, Inorganic chemistry.

[22]  I. Mutikainen,et al.  Triclinic Form of Tetraaqua(orotato-N,O)magnesium(II) Hydrate at 153K , 1996 .

[23]  E. Baran,et al.  Crystal structure, raman and 57Fe mo¨ssbauer spectra of the FeII complex of iso-orotic acid , 1996 .

[24]  David J. Williams,et al.  Molecular recognition of 2,6-diaminopyridine by platinum orotate complexes , 1996 .

[25]  Andrew J. P. White,et al.  5-Aminoorotic acid, a versatile ligand with the ability to exhibit differing co-ordination and hydrogen-bonding modes: synthesis and crystal structures of platinum(II) complexes , 1996 .

[26]  D. Mingos,et al.  Multidimensional crystal engineering of bifunctional metal complexes containing complementary triple hydrogen bonds , 2010 .

[27]  R. Christopherson,et al.  MODELS OF THE ACTIVE SITE OF DIHYDROOROTASE : STRUCTURE OF DIAQUABIS(L-DIHYDROOROTATO)ZINC(II) REVEALS AN UNEXPECTED COORDINATION MODE FOR THE L-DIHYD ROOROTATO LIGANDS , 1995 .

[28]  F. Hueso-Ureña,et al.  Silver(I), palladium(II), platinum(II) and platinum (IV) complexes with isoorotate and 2-thioisoorotate ligands: synthesis, i.r. and n.m.r. spectra, thermal behaviour and antimicrobial activity , 1995 .

[29]  J. Jaud,et al.  New polynuclear manganese(II) complexes with orotic acid and some of its derivatives: crystal structures, spectroscopic and magnetic studies , 1995 .

[30]  H. Vahrenkamp,et al.  Pyrazolylborat‐Zinkkomplexe mit Medikament‐Liganden , 1994 .

[31]  H. Vahrenkamp,et al.  Funktionelle Zinkkomplexe von Tris(imidazolylmethyl)amin-Liganden , 1994 .

[32]  G. Bernardinelli,et al.  Synthesis, characterization and X-ray crystal structure of ethylenediamine-(orotato)palladium(II) , 1994 .

[33]  J. Hickman,et al.  bcl-2 modulation of apoptosis induced by anticancer drugs: resistance to thymidylate stress is independent of classical resistance pathways. , 1993, Cancer research.

[34]  H. Schmidbaur,et al.  Preparation and Crystal Structure of Zinc Bis[orotate(1–)] Octahydrate , 1993 .

[35]  John Calvin Reed,et al.  Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line. , 1993, Blood.

[36]  S. Perlepes,et al.  Coordinating properties of isoorotic acid , 1992 .

[37]  H. Schmidbaur,et al.  Orotate Complexes, II1) Preparation and Crystal Structures of Calcium and Zinc Orotate(2‐) Hydrates , 1991 .

[38]  W. Hiller,et al.  Reaction of dimethylhydroxythallium(III) with 2-thioorotic acid. Crystal structure of dimethyl(2-thioorotato)thallium(III) monohydrate , 1991 .

[39]  H. Schmidbaur,et al.  Orotate complexes. Synthesis and crystal structure of lithium orotate(—I) monohydrate and magnesium bis[ orotate(—I)] octahydrate , 1990 .

[40]  H. Schmidbaur,et al.  Aspartic and Glutamic Acid as Ligands to Alkali and Alkaline‐Earth Metals: Structural Chemistry as Related to Magnesium Therapy , 1990 .

[41]  R. Christopherson,et al.  Potent inhibitors of de novo pyrimidine and purine biosynthesis as chemotherapeutic agents , 1990, Medicinal research reviews.

[42]  C. Valenzuela-Calahorro,et al.  Thermal, spectral and biological studies or metal complexes of isoorotic and 2-thioisoorotic acids , 1988 .

[43]  Kazuko Matsumoto.  Antitumor activities of platinum blues containing α-pyrrolidone, 3,3-dimethylglutarimide, orotic acid, succinamic acid and oxamic acid , 1988 .

[44]  D. Mentzafos,et al.  Synthesis and structure of bis(orotato)dioxouranium(VI) pentahydrate , 1987 .

[45]  I. Mutikainen.  The crystal structure of triammine(orotato)zinc(II) monohydrate , 1987 .

[46]  E. Biehl,et al.  Substituent and solvent effects on tautomeric equilibria of barbituric acid derivatives and isoterically related compounds , 1987 .

[47]  B. Thomas,et al.  The structures of tetraaqua(uracil-6-carboxylate)zinc(II) monohydrate (A) and tetraaqua(uracil-6-carboxylato)nickel(II) monohydrate (B) , 1986 .

[48]  D. Evans,et al.  The dihydroorotase domain of the multifunctional protein CAD. Subunit structure, zinc content, and kinetics. , 1986, The Journal of biological chemistry.

[49]  J. Laurent,et al.  Intramolecular influence of a carboxylic function on platinum blue synthesis. A systematic study of complexes originating from acid amides , 1984 .

[50]  J. Laurent,et al.  Carboxy uracil and some of its derivatives as complexant toward platinum. Platinum blues , 1984 .

[51]  J. Laurent,et al.  Palladium(II) complexes of orotic acid and derivatives: multiplicity of their binding sites , 1984 .

[52]  F. Dahan,et al.  Coordination sites of 5-nitro-6-carboxyuracil: UV study and x-ray structure determination of diammine(5-nitroorotato)copper(II) hydrate and hexaamminebis(5-nitroorotato)tricopper(II) pentahydrate , 1983 .

[53]  A. Singh,et al.  Analytical reactions of 5-amino-orotic acid. , 1983, Talanta: The International Journal of Pure and Applied Analytical Chemistry.

[54]  J. Dubois,et al.  Etude de la protonation lente des complexes entre l’ion nickel divalent et le dianion de l’acide orotique ou ses dérivés , 1982 .

[55]  K. Fuwa,et al.  The crystal structure of cis-diammine(orotinato)platinum(II). , 1981 .

[56]  I. Mutikainen,et al.  The structure of diammine(orotato)copper(II) , 1980 .

[57]  M. Sabat,et al.  Tetraaquaorotatonickel(II) monohydrate , 1980 .

[58]  G. Dodin,et al.  Tautomerism of orotic acid dianion. Effect of calcium and magnesium cations on the tautomeric constant and on tautomerization dynamics , 1980 .

[59]  N. Karayannis,et al.  Nicotinic and isonicotinic acid n-oxide interactions with 3d metal perchlorates[1] , 1980 .

[60]  J. Victor,et al.  Studies of the kinetic mechanism of orotate phosphoribosyltransferase from yeast. , 1979, The Journal of biological chemistry.

[61]  K. Nakamoto.  Infrared and Raman Spectra of Inorganic and Coordination Compounds , 1978 .

[62]  D. B. Mccormick,et al.  Evidence for function of a metal ion in the activity of dihydroorotase from Zymobacterium oroticum. , 1965, The Journal of biological chemistry.

[63]  L. M. Jackman.  Applications of nuclear magnetic resonance spectroscopy in organic chemistry , 1959 .

[64]  A. Kornberg,et al.  Enzymatic synthesis of pyrimidine nucleotides; orotidine-5'-phosphate and uridine-5'-phosphate. , 1955, The Journal of biological chemistry.

[65]  D. Shugar,et al.  Spectrophotometric studies of nucleic acid derivatives and related compounds as a function of pH. I. Pyrimidines. , 1952, Biochimica et biophysica acta.